Bank of New York Mellon’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,065
| Closed | -$111K | – | 4579 |
|
|
2022
Q1 | $111K | Hold |
2,065
| – | – | ﹤0.01% | 4386 |
|
|
2021
Q4 | $612K | Buy |
2,065
+125
| +6% | +$37K | ﹤0.01% | 3665 |
|
|
2021
Q3 | $752K | Buy |
1,940
+123
| +7% | +$47.7K | ﹤0.01% | 3564 |
|
|
2021
Q2 | $926K | Buy |
1,817
+546
| +43% | +$278K | ﹤0.01% | 3469 |
|
|
2021
Q1 | $723K | Buy |
1,271
+67
| +6% | +$38.1K | ﹤0.01% | 3501 |
|
|
2020
Q4 | $832K | Buy |
+1,204
| New | +$832K | ﹤0.01% | 3352 |
|